24 Dec 2010              

Nicotine e-cigarette cartridges can be sold as tobacco products

 

End Smoking NZ, a charitable trust focussed on tobacco policy, has identified the sale of safer, satisfying nicotine products as a top priority for greatly reducing smoking.1  Tobacco smoke includes thousands of compounds, including carcinogens, and lung and cardiovascular toxicants. In contrast, pure nicotine carries far less risk, and can provide a safer alternative for those too addicted to yet quit smoking. 

 

Medsafe’s interpretation of the Medicines Act is that nicotine electronic (e-)cigarettes (which vapourise nicotine into a mist for inhalation) are  medicines “even if they are not represented as aids to smoking cessation”,2 and cannot be sold unless medicinally licensed. As no such licensing is imminent, a virtual ban is in place.

Instead, we argue that nicotine e-cigarettes are primarily recreational nicotine alternatives to smoking, though some brands may obtain licensing as medicines at some future date. We argue they already qualify as tobacco products under the Smoke-free Environments (SFE) Act, which has regulated all tobacco products for (recreational) human consumption since 1990. For example, at Section 30, the Act bans their sale to those under 18 years of age, while at Section 31 it has powers to reduce or remove any substances deemed hazardous. All that e-cigarette distributors would have to do, is strictly refrain from making therapeutic claims, and abide by current or future regulations of the SFE Act. We now examine how the SFE Act can accommodate nicotine electronic cigarettes. 

 

The SFE Act’s interpretation section defines a tobacco product as:

 

     “any product manufactured from tobacco and intended for use by smoking, inhalation, or mastication and includes nasal and oral snuff, but does not include any medicine (being a medicine in respect of which there is in force a consent or provisional consent under section 20 or section 23 of the Medicines Act 1981) that is sold or supplied wholly or principally for use as an aid in giving up smoking.”

 

Thus the nicotine e-cigarette can be classified as a tobacco product, if its nicotine is manufactured from tobacco (it is) and it is not supplied wholly or principally as an aid in giving up smoking.3 Nicotine e-cigarettes, unlike medicinal nicotine patches or gum, are shaped and designed to provide nicotine-based and smoking-ritual-based pleasure by inhalation, and so can be regarded as tobacco products provided no medicinal claims are made. A recent United States district court decision,4 upheld on appeal in December 2010, supports the classification of e-cigarettes as inhaled tobacco products, and recognises that almost all nicotine is consumed for recreational, not medicinal purposes.

 

According to the definition above, tobacco products can be used for smoking, inhalation or mastication. Of these three, the SFE Act permits sale for smoking, but not for oral use, and does not mention sale for inhalation: 

 

    “No person shall import for sale, sell, pack, or distribute any tobacco product labelled or otherwise described as suitable for chewing, or for any other oral use (other than smoking)”.5

 

Sale of nasal tobacco snuff for inhalation remains legal. Sale of nicotine electronic cigarettes for inhalation is not mentioned; and their import, distribution and sale can we believe, be allowed under the SFE Act. This is reinforced by observations on how e-cigarettes are used – for inhalation, not oral use.

 

As with cigarettes the e-cigarette mist is inhaled, but more negative pressure is needed,6 requiring inhalation directly to the lungs. Smokers switching to e-cigarettes, instead of holding smoke in the mouth before inhalation as many smokers do, learn to inhale mist into the lungs in a one-stage manoeuvre. The mouth has a separate secondary role as part of the respiratory tract, and the inhaled mist transits the mouth in seconds, whereas oral products (snuff or nicotine gum) are normally held in the mouth for half an hour. For the above reasons, we believe the sale of electronic cigarettes is not caught by the Act’s ban on sale of oral tobacco products.

 

As nicotine e-cigarettes contain no tobacco, they attract no tobacco excise. Nicotine-free electronic cigarettes are widely advertised and sold, but most users want nicotine cartridges – which, being tobacco products, cannot be advertised (Section 22, SFE Act). Every nicotine cartridge sold means a pack of cigarettes not sold. UK surveys have shown 52% of smokers have heard of e-cigarettes but never tried them, 6% of smokers have tried them but no longer use them, and 3% currently use them.7 

The Maori Affairs Select Committee Tobacco Inquiry recommended further research into the benefits and risks of alternative products.8

A recent review backs e-cigarettes as much safer than cigarettes, although absolute safety is yet to be proven.9  Further reliance, however, on regulation solely under the Medicines Act, as at present, would deny satisfaction to the thousands of smokers who have already bought e-cigarettes without nicotine, as currently advertised. No hospitalizations or deaths have been reported globally so far from over 3 years of nicotine e-cigarette sales.  Smokers merely want the choice now, without having to order the nicotine cartridges from China.

Conclusion The Smoke-free Environments Act provides a comprehensive framework for governing recreational tobacco and nicotine, and already permits the import, distribution, and sale of nicotine electronic cigarettes as tobacco products.

 

Murray Laugesen, Marewa Glover, Trish Fraser, Ross McCormick, John Scott. (board members, End Smoking NZ trust).

________________________

1. Laugesen M. Glover M, Fraser T, McCormick R, Scott J.  Four policies to end the sale of cigarettes and smoking tobacco in New Zealand by 2020.   NZ Med J 14 May 2010, Vol 123 No 1314; ISSN 1175 8716 URL: http://www.nzma.org.nz/journal/123-1314/4107/

 

2 Medical devices, Categorisation of electronic cigarettes. Medsafe website, accessed 22 Dec 2010.  http://www.medsafe.govt.nz/regulatory/medicaldevices/electroniccigarettes.asp

 

3. Laugesen M.  Nicotine electronic cigarette sales are permitted under the Smokefree Environments Act. Letter.   29-Jan-2010 - Vol 123 No 1308 NZ Med J 29-January-2010, Vol 123 No 1308.

 

4. Smoking Everywhere Inc and Sottera Inc c/b/a NJoy v. US Food and Drug Administration et al (defendants). Civil case 09-771 (RJL) Memorandum Opinion Jan 14, 2010. US District Court for the District of Columbia.

 

5. Smoke-free Environments Act, section 29(2). http://www.legislation.govt.nz/act/public/1990/0108/latest/DLM224309.html?search=ts_act_Smoke-free+Environments+Act_resel&p=1    

 

6. Trtchounian A, Williams Williams M, Talbot P. Conventional and electronic cigarettes (e-cigarettes) have different smoking characteristics, Nicotine Tob Res. 2010 Sep;12(9):905-12. Epub 2010 Jul 19.

 

7. Dockrell M. What smokers tell us about e-cigarettes. Society for Research on Nicotine and Tobacco Conference (Europe), Bath, England 2010.

 

8. Maori Affairs Committee. Inquiry into the tobacco industry in Aotearoa and the consequences of tobacco use for Maori. Report. Forty-Ninth Parliament. Hon Tau Henare, chairperson. Wellington, November 2010. p.40. 

http://www.parliament.nz/NR/rdonlyres/C6AAA494-A706-48C6-8F91-6CAF5EA7CA51/164754/DBSCH_SCR_4900_InquiryintothetobaccoindustryinAote.pdf 

 

9. Cahn Z, Siegel M. Electronic cigarettes as a harm reduction strategy for tobacco control: A step forward or a repeat of past mistakes? J Public Health Policy. 2010, 9 Dec. doi:10.1057/jphp.2010.41, 1-16.

_________________________________________________________________________________________

June 2006: Three options for smokers.   (Written before the advent of e-cigarettes)

Without using the internet, the only way New Zealand smokers can get addictive nicotine today is to smoke. The nicotine gum patch and lozenges at the pharmacy are useful for smokers wanting to quit smoking, but most smokers are not ready to quit if that means giving up addictive nicotine. Quitting smoking and nicotine at the same time means that most quitters soon go back to smoking to get their addiction needs met.

 

Smokeless New Zealand (now End Smoking NZ) a new charitable trust has been formed to advocate for more choices for smokers, so smokers don’t have to give up nicotine just to quit smoking. Chair Dr Murray Laugesen says “The smoke is what kills people, but the nicotine is what smokers want, and the two can be separated.”

 

Smokers smoke for nicotine, and 4000 smokers a year leave their quitting too late. They often get no second chance, as by the time they know they have lung cancer it has spread too far. The new warnings on packets next year will increase the pressure on smokers to quit, but too many will still find it very difficult. Is there some way for smokers to quit smoking and still get their nicotine?

 

1. The first option is to keep on smoking, but the risks from smoking are extreme - cigarettes eventually kill half of those who continue to smoke past age 35. Almost anything else (including being a soldier in war for a few years) is safer.

 

2. The second option is to quit smoking and tobacco all at once 

Smokers wanting to quit smoking and tobacco together should contact their doctor or the QuitLine 0800 778 778, or if they are ready to do it and sure of success, go cold turkey. This is the ideal, for those who have decided to be drug-free. www.quit.org.nz

 

3. The third option is to switch to addictive nicotine. Those who don’t want to quit nicotine just yet, should still quit smoking for their own safety. Several products that can provide smokers with addictive nicotine:

 

3.1 Patches and gum First, many nicotine addicts find it difficult to get enough nicotine from patches and gum.  If they use both together they find they do better. 

A nicotine patch gives a steady background level of nicotine. To take care of sudden urges to smoke, many quitters chew on 4mg nicotine gum which they gives them a nicotine effect after say ten minutes. Gum and patches are sold in supermarkets and pharmacies. If people smoke at the same time as using these nicotine medications, they may feel slightly sick, it means they are getting as much nicotine as they need, and should now cut down on cigarettes until they rely on the nicotine gum and patch only for their nicotine. www.endsmoking.org.nz/nrt.htm

 

3.2 Nasal snuff. This traditional product will be going on sale in 2006. Regular users obtain high levels of nicotine, equal to cigarettes. It gives a nicotine hit  quickly, within two minutes. It is legal to sell it, and specialist tobacconists are likely to stock it. It is addictive, may cause disease, but is much safer than cigarettes. Now that smoking is known to kill half of continuing smokers, snuff could come back into fashion. 

 

 

Because it has not been used it has not been studied, and little is known about its effects. The safest nasal snuff with the lowest nitrosamines is from Swedish Match. As the risks are likely to be similar to oral snuff, (see below) nasal snuff, if it helps smokers to switch off smoking, will avoid the high risks of smoking, and used for the first year or so after stopping smoking, will reduce the risk of relapse to smoking. Because of its fast action, it will be useful if kept handy as an emergency source of nicotine, and used to satisfy and counter the urge to smoke. Like glasses at parties it is best not shared between friends. www.endsmoking.org.nz/nasalsnuff.htm

 

3.3 Oral snuff. This Swedish traditional smokeless tobacco has to be ordered on the internet. It is barred from sale in New Zealand. It costs about two thirds as much as cigarettes. The only snuff worth using is made in Sweden, and is very low in nitrosamines (under 5 parts per million) and is unlikely to cause cancer. It is used by a million Swedes, mostly men, many times daily. Some 200,000 Swedish women now dip snuff. It is spitless, and used in the form of a small teabag under the upper lip.  It is kept there for half an hour and over the course of a day provides nicotine levels higher than nicotine patches or gum. Dry snuff does not have to be refrigerated before sale.

It is about 5% as dangerous as cigarette smoking, and the risk of the uncommon mouth cancer, is one in five of the risk for smokers. Smokers use it instead of going outside in the cold to smoke. As long as people are satisfying their need for nicotine by not smoking, they are 95% better off health-wise. www.endsmoking.org.nz/snusaidsquitting.htm www.endsmoking.org.nz/snus.htm

 

3.4. Fast nicotine

Fourthly, pure addictive nicotine products are under research and development here in New Zealand. Nicotine tea-bag-like pouches placed under the upper lip like Swedish snuff are to tested later this year in Auckland; also other oral forms.  In Wellington , nicotine inhalers are being tested. These products are several years away from commercial sale, but they have virtually zero risks, and eventually if they are shown to be addictive for smokers, may be able to do away with the need for smokeless tobacco snuff altogether. A world wide market awaits the successful biotech companies which can make this happen. www.endsmoking.org.nz/fastnic.htm

To policy writers:

  • Addiction to tobacco varies greatly among smokers. Some give up smoking without difficulty, others never, though they know the risks.
  • Non smokers may find it repugnant, but many smokers are nicotine addicts, and this fact is accepted by health workers who deal with smokers, and listen to their story.
  • Seeing it from the smokers’ point of view, perhaps nonsmokers will concede that smokers have a right to be informed and to make their own nicotine choices.

To health professionals:

“We should be aiming to move smokers along the continuum of nicotine-delivery away from the most harmful delivery systems (cigarettes) primarily by encouraging as many smokers to quit, but failing that, then by encouraging them to use clean nicotine-delivery products, and failing that, regulated smokeless-tobacco products.”

- McNeill A. in Colby SM, Drobes DJ, West R. International advances in nicotine and tobacco research. 11th Annual Meeting Society for Research on Nicotine and Tobacco, Prague, Czech Republic, 20 – 23 March 2005. Nicotine Tob Res 2005; 7: 667-709, at p. 669.

 Dr Murray Laugesen QSO chair; Prof Ross McCormick, Sir John Scott KBE, Trish Fraser MPH, Dr Marewa Glover, Trustees

Safer substitutes can virtually eliminate the harm from smoking cigarettes © 2010 End Smoking NZ